Recent funding news stories and opportunities are listed below.
If you require support or are considering applying for funding, consider contacting Markel, Bionow's preferred Partner for R&D funding solutions, who offer the expertise required to maximise your success and also discounts for Bionow members.
If you require support or are considering applying for funding, consider contacting Markel, Bionow's preferred Partner for R&D funding solutions, who offer the expertise required to maximise your success and also discounts for Bionow members.
UK BioPharma Visit to Barcelona
Dec 16th 2024
Deadline 7th January to join FCDO Trade Mission to Barcelona
Competition seeks novel technology options or technical approaches that can directly support the UKMFC initiative.
Canada-UK Collaborative R&D
Nov 14th 2024
UK registered organisations can apply for a share of up to £3 million for collaboration with Canadian SMEs on joint R&D projects.
EPSRC Place Based Impact Acceleration Account
Nov 11th 2024
Innovating Medical Technologies Across the Yorkshire Region
UK registered businesses can apply for funding for life science manufacturing capital investment projects which help increase UK health resilience.
Monument Therapeutics, a leader in precision neuroscience, has announced a significant £1 million equity investment from the Forster Foundation, a charitable organization.
MedTech Accelerator: Rapid Regulatory Support Fund
Oct 9th 2024
£4.2m funding available to support UK SMEs with MedTech regulations
Innovation in Life Sciences: Call for proposals
Oct 9th 2024
The Hartree National Centre for Digital Innovation (HNCDI) partners, STFC and IBM Research, in cooperation with Bionow and The European Laboratory Research & Innovation Group (ELRIG), are is...
PACE (Pathways to Antimicrobial Clinical Efficacy) has today launched its second funding round with up to £5 million available to support cutting-edge diagnostic projects. This funding is p...
The Cystic Fibrosis Antimicrobial Resistance Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme funding.
F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening rare fungal infections with a high unmet medical nee...
With an initial investment of £28 million in resource and funding from LifeArc and Cancer Research UK, the consortium will bring together researchers, clinicians, scientists and industry to...
Latest Jobs
